Drug
Indv 6001
Indv 6001: highest development phase Phase 2, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| INDV-6001 NCT06576843 | Phase 2 | Moderate to Severe Opioid Use Disorder |
Latest
No recent events.
Follow Indv 6001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.